HomeMOLN • NASDAQ
add
Molecular Partners AG
Nakaraang pagsara
$4.32
Sakop ng araw
$4.32 - $4.70
Sakop ng taon
$3.32 - $12.70
Market cap
178.36M USD
Average na Volume
2.52K
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (CHF) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 0.00 | -100.00% |
Gastos sa pagpapatakbo | 52.85M | 815.93% |
Net na kita | -11.23M | 43.22% |
Net profit margin | — | — |
Kita sa bawat share | -0.30 | — |
EBITDA | -14.22M | 13.35% |
Aktuwal na % ng binabayarang buwis | -0.02% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (CHF) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 149.44M | -20.04% |
Kabuuang asset | 158.53M | -20.08% |
Kabuuang sagutin | 16.89M | -22.95% |
Kabuuang equity | 141.64M | — |
Natitirang share | 36.71M | — |
Presyo para makapag-book | 1.12 | — |
Return on assets | -23.65% | — |
Return on capital | -25.90% | — |
Cash Flow
Net change in cash
| (CHF) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -11.23M | 43.22% |
Cash mula sa mga operasyon | -13.20M | 17.47% |
Cash mula sa pag-invest | -4.49M | -123.10% |
Cash mula sa financing | 15.30M | 5,234.56% |
Net change in cash | -1.88M | -72.29% |
Malayang cash flow | -12.16M | -29.92% |
Tungkol
Molecular Partners AG is a clinical-stage biopharmaceutical company based in Zürich, Switzerland. The company is developing a new class of potent, specific and versatile small-protein therapies called DARPins, with potential clinical applications in a range of disease areas including oncology, immuno-oncology, ophthalmology, and infectious diseases. Molecular Partners currently has two DARPin molecules in clinical development, and a broad pipeline of molecules in preclinical development. Wikipedia
Itinatag
2004
Website
Mga Empleyado
162
